Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 2/2020

01-04-2020 | Coronavirus | Commentary

Providing pharmacy services during the coronavirus pandemic

Authors: Shao Liu, Ping Luo, Mimi Tang, Qin Hu, Joseph P. Polidoro, Shusen Sun, Zhicheng Gong

Published in: International Journal of Clinical Pharmacy | Issue 2/2020

Login to get access

Abstract

The coronavirus disease 19 (COVID-19) is quickly spreading across China and globally. Pharmacy services are an important pillar in public health to prevent and contain the COVID-19 pandemic. Chinese pharmacists have acted swiftly in the public health response in China, such as drafting professional service guidance to pharmacists and pharmacies, establishing emergency drug formularies, monitoring and resolving drug shortages, establishing remote pharmacy services to prevent human-to-human infections, providing event-driven pharmaceutical care, educating the public on infection prevention and disease management, and participating in clinical trials and drug evaluation. This commentary reviews the unique needs of pharmacy services in the COVID-19 pandemic, and shares our experiences with the international pharmacy community in the response to these needs.
Literature
2.
go back to reference Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–33.CrossRef Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–33.CrossRef
4.
go back to reference Liu S, He G, Du J, Wang D, Shi C, Huang Q, et al. Pharmaceutical emergency guarantee difficulties and countermeasures for the prevention and control of outbreak of novel coronavirus pneumonia (NCP). Chin J Hosp Pharm. 2020;40(3):243–9. Liu S, He G, Du J, Wang D, Shi C, Huang Q, et al. Pharmaceutical emergency guarantee difficulties and countermeasures for the prevention and control of outbreak of novel coronavirus pneumonia (NCP). Chin J Hosp Pharm. 2020;40(3):243–9.
9.
go back to reference Fox ER, McLaughlin MM. ASHP guidelines on managing drug product shortages. Am J Health Syst Pharm. 2018;75(21):1742–50.CrossRef Fox ER, McLaughlin MM. ASHP guidelines on managing drug product shortages. Am J Health Syst Pharm. 2018;75(21):1742–50.CrossRef
15.
go back to reference Maxmen A. Slew of trials launch to test coronavirus treatments in China. Nature. 2020;578:347–8.CrossRef Maxmen A. Slew of trials launch to test coronavirus treatments in China. Nature. 2020;578:347–8.CrossRef
Metadata
Title
Providing pharmacy services during the coronavirus pandemic
Authors
Shao Liu
Ping Luo
Mimi Tang
Qin Hu
Joseph P. Polidoro
Shusen Sun
Zhicheng Gong
Publication date
01-04-2020
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 2/2020
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-020-01017-0

Other articles of this Issue 2/2020

International Journal of Clinical Pharmacy 2/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.